The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol —study protocol
ConclusionsThe Excited-UA study would provide novel evidence for the clinical relevancy of xanthine oxidoreductase inhibitor treatment in patients with chronic heart failure and hyperuricemia.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research
More News: Allopurinol | Brain | Cardiology | Cardiovascular | Clinical Trials | Heart | Heart Failure | Neurology | Study | Urology & Nephrology